Robert B. Aderholt Stock Trades

Robert B. Aderholt Congressional Trading Profile | Quantellect Robert B. Aderholt Congressional Trading Profile

Robert B. Aderholt's disclosure record is notable for what it lacks. Across the entire span captured in Quantellect's transaction database, the Alabama Republican's filings contain three securities transactions, dated between August 26, 2022 and July 28, 2025. One purchase. Two sales. Every one of them fell inside the same disclosed amount band of $1,001 to $15,000, the narrowest and lowest bracket that House filers are required to report under the House financial disclosure instructions.

That places him at the quiet end of a chamber where quiet is common. Of the 537 sitting members of Congress measured on August 23, 2026, 276 have no disclosed trades at all, including 237 of the 437 House members. Aderholt sits just above that line: technically an active filer, but with only three transactions recorded across 2022 and 2025.

The most recent entry is a sale of GSK plc American Depositary Shares, transacted July 28, 2025 and disclosed on September 10, 2025. It is attributed to the member himself. GSK is the London-headquartered pharmaceutical group, founded in 1715 and renamed from GlaxoSmithKline in May 2022, that develops vaccines, specialty medicines and general medicines. Quantellect classifies it under Health Care, industry Pharmaceuticals. The company runs two segments, Commercial Operations and Total R&D, and its franchise spans oncology, respiratory and immunology, HIV, lupus and lupus nephritis, and ovarian and endometrial cancer, alongside a vaccine book covering shingles, meningitis, RSV, seasonal influenza, hepatitis and HPV, among others. GSK also carries collaboration agreements with CureVac on mRNA vaccines for infectious diseases, with Engitix on liver fibrosis targets, and with AN2 Therapeutics on tuberculosis therapies. Quantellect's company description presents a vaccine-and-specialty-medicine business supported by research and development, while the transaction record identifies GSK as the sole Health Care security disclosed in 2025. The filing is public here.

Three trades across three sectors

The other two transactions both land in 2022, and they are the reason the record is more interesting than its size suggests.

On August 26, 2022, disclosed September 23, 2022, a purchase of Apple Inc. was reported under the member's own name. Apple is filed under Information Technology, industry Technology Hardware, Storage and Peripherals. The business is the familiar one: iPhone, Mac, iPad, and the wearables and accessories line including AirPods, Apple Watch, Apple Vision Pro, Apple TV, Beats and HomePod. Underneath the hardware is a broad services business spanning the App Store, AppleCare and cloud services, advertising, and the subscription stack of Apple Arcade, Apple Fitness+, Apple Music, Apple News+ and Apple TV, plus Apple Card and Apple Pay. The company serves consumers, businesses, education, enterprise and government markets through its own stores and sales force as well as third-party carriers and resellers. Founded in 1976 and headquartered in Cupertino, it renamed from Apple Computer, Inc. in January 2007. See the original disclosure.

Then, on December 5, 2022, with disclosure on December 13, came a sale of Tesla Inc. And here the attribution matters more than the ticker. Quantellect's data assigns that transaction the code DC, dependent child. It is not recorded as the member's own trade. Anyone reading this record as a portrait of one person's decision-making should note that one of the three transactions is attributed to a dependent child under the member's disclosure umbrella. Of the three, two carry a SELF attribution and one carries DC. None are attributed to a spouse, a joint account, or an unknown holder.

Tesla itself is classified under Consumer Discretionary, industry Automobiles. The company designs, manufactures, leases and sells electric vehicles and energy generation and storage systems across the United States, China and internationally, operating two segments, Automotive and Energy Generation and Storage. Beyond the vehicles and the Supercharger network, the business includes solar generation and the Powerwall and Megapack lithium-ion storage products, plus self-driving development and artificial intelligence software, vehicle control and infotainment software, and battery and powertrain work. Incorporated in 2003, renamed from Tesla Motors in February 2017, and headquartered in Austin. The December 2022 filing is here.

What the pattern actually says

Sector concentration is impossible in a file this thin, and the data reflects that. The three transactions distribute one apiece across Consumer Discretionary, Health Care and Information Technology. That is the complete sector list, not a selection from a longer one. There is no repeated name: Apple, GSK and Tesla each appear exactly once in the most-frequently-disclosed ranking, which is ordered by transaction-row count rather than by any measure of size or conviction.

The year-by-year shape is equally spare. 2022 produced two transactions, one purchase and one sale. 2025 produced one, a sale. There is no disclosed activity between those two points in the record. What the file supports is a description of two separate episodes: a self-attributed Apple purchase and a Tesla sale attributed to a dependent child in 2022, followed by a self-attributed GSK sale in 2025.

One more absence is worth flagging plainly. Aderholt has no Quantellect Score at the latest published score date of August 23, 2026. Only 77 of the 537 sitting members carry one, so the gap is the norm rather than the exception. The database records only that no score row exists for Aderholt at that date; it supplies no formula version, tier, coverage state or rank for him.

For an investor scanning congressional disclosure as a signal source, the honest reading of this record is that it offers very little to work with, and that is itself the finding. Aderholt's filings show a member who reports rarely, in the smallest disclosable band, without repetition, and with one of the three transactions attributed to a dependent child. Filings of this type are governed by the Stop Trading on Congressional Knowledge Act of 2012, which establishes the periodic transaction reporting regime and its reporting windows, with the mechanics detailed in the House Committee on Ethics financial disclosure instruction guide. In each entry described above, the disclosure date follows the transaction date, a reminder that even a complete disclosure record reaches the public after the reported transaction occurred.

Disclosure and methodology

This profile is published by Quantellect and is drawn from Robert B. Aderholt's official periodic transaction reports filed with the Clerk of the House, as captured in Quantellect's transaction database. Transaction dates and disclosure dates are distinct and are reported separately throughout. All amounts are the disclosed ranges required by House rules, not exact values.

Attribution follows the codes carried in the underlying filings. SELF indicates the filer, SP a spouse, JT a joint account and DC a dependent child. A transaction disclosed under a member's name is not necessarily a personal investment decision, and may reflect the activity of a spouse, dependent, trust, adviser or managed account.

Nothing here is investment advice, a recommendation, or an endorsement of any security. Quantellect makes no claim about the reasons behind any disclosed transaction. Population figures, counts and score availability are as measured on August 23, 2026, and the record described is limited to what appears in the disclosures cited above.